Analysis of effectiveness of human U-500 insulin in patients unresponsive to conventional insulin therapy.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Endocrine Practice

• Publication date

  2005-08-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.4158/EP.11.5.305PMID 16191489
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A caution regarding U-500 insulin by continuous subcutaneous infusion.

  2004cited by this paper
• A novel use of U-500 insulin for continuous subcutaneous insulin infusion in patients with insulin resistance: a case series.

  2003cited by this paper
• Successful outcome of pregnancy in a patient with generalized lipoatrophic diabetes mellitus.

  2000cited by this paper
• Five fold increase of insulin concentration delays the absorption of subcutaneously injected human insulin suspensions in pigs.

  2000cited by this paper
• Insulin Resistance and the Use of U-500 Insulin: A Case Report

  1987cited by this paper
• American Journal of Medicine, March 1984, pp 529-32 Enhanced efficacy of U-500 insulin in the treatment of insulin resistance caused by target tissue insensitivity

  1984cited by this paper
• [Prolonged effects of unaltered insulin of high concentration: U-500 unmodified insulin, Lilly].

  1959cited by this paper

• A simplified straightforward protocol for the use of U‐500 regular insulin

  2022cites this paper
• Treatment patterns and outcomes before and after human regular U-500 insulin initiation via KwikPen® among US veterans with type 2 diabetes mellitus.

  2021cites this paper
• A case series of Humulin R U‐500 in insulin resistant people with type 2 diabetes

  2021cites this paper
• The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: a cohort survey.

  2021cites this paper
• Case Series of U-500 Insulin Use in Adults With Type 2 Diabetes and Severe Insulin Resistance.

  2020cites this paper
• A Clinical Review of Concentrated Insulins for Type 1 and Type 2 Diabetes Mellitus

  2017cites this paper
• Translating U-500R Randomized Clinical Trial Evidence to the Practice Setting: A Diabetes Educator/Expert Prescriber Team Approach

  2017cites this paper
• A comparative analysis of pharmacists' self-confidence beliefs for regular U-500 (concentrated) insulin and U-100 insulin

  2016cites this paper
• Pharmacologic Treatment of Type 2 Diabetes

  2015cites this paper
• Application of PK/PD Modeling and Simulation to Dosing Regimen Optimization of High-Dose Human Regular U-500 Insulin

  2014cites this paper
• A Practical Guide to Concentrated Insulin for Pharmacists

  2014cites this paper
• Practice Tips and Tools for the Successful Use of U-500 Regular Human Insulin

  2014cites this paper
• The use of U‐500 regular insulin in the management of patients with obesity and insulin resistance

  2013influential citation
• Insulin therapy for type 2 diabetes

  2013cites this paper
• Clinical Use of U-500 Regular Insulin: Review and Meta-Analysis

  2012cites this paper
• Durability of glycemic control using U-500 insulin.

  2012cites this paper
• Bioavailability and variability of biphasic insulin mixtures.

  2012cites this paper
• U500 regular insulin use in insulin-resistant type 2 diabetic veteran patients.

  2012cites this paper
• Safety and Effectiveness of U‐500 Insulin Therapy in Patients with Insulin‐Resistant Type 2 Diabetes Mellitus

  2011cites this paper
• Absorption Kinetics of Insulin Mixtures after Subcutaneous Administration

  2011cites this paper
• Extreme Insulin Resistance: Indications and Approaches to the Use of U-500 Insulin in Type 2 Diabetes Mellitus

  2011cites this paper
• Type 2 Diabetes: Uses of thiazolidinediones and insulin

  2011cites this paper
• Type 2 Diabetes

  2011cites this paper
• Use of concentrated insulin human regular (U-500) for patients with diabetes.

  2010cites this paper
• Clinical efficacy and patient satisfaction with U-500 insulin use.

  2010cites this paper
• diabetes mellitus Insulin U-500 in severe insulin resistance in type 2

  2009cites this paper
• High-dose insulin therapy: is it time for U-500 insulin?

  2009cites this paper
• Delivery of U‐500 insulin by CSII in a patient with type 2 diabetes and extreme insulin resistance

  2009cites this paper
• Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus

  2009cites this paper
• U‐500 insulin: why, when and how to use in clinical practice

  2007cites this paper
• Exposure to Rosiglitazone and Fluoxetine in the First Trimester of Pregnancy

  2006cites this paper
• Recent Trend Toward Decrease in the Incidence of Childhood Type 2 Diabetes in Tokyo

  2006cites this paper
• Use of U-500 Regular Insulin in Type 2 Diabetes

  2006cites this paper